Heinz, Its a very simple answer, Its in Abbott's hands now, They control the future of bg medicine.
There's a few ways this could go, Abbott could buy BGM, I don't think this will happen, Mainly because Abbott wants to know the value of the test first, Once they do, They may choose to buy BGM.
They do have an agreement with BGM, Nobody knows what's in it, It just may be a fee based agreement, Or it may be an upfront payment with fee based revenues, Nobody knows.
The one thing we do know is , We need CASH, There are ways to get it, But most will bring dilution, which is not good for the shareholders here.
I personally think this technology is the future of diagnostic tests for many diseases, And BGM is the leader here, The one thing that is BGM's most valuable asset is the BioImage Study, Many forget that.
Here's your problem, This company is poorly run by what seems to be incompetent people, They don't give a rat's behind about shareholders, My worry here is the company is selling us down the river, I hope not for their sake, They would be in the courts for years.
Come on king, We're worried about you, I think he sold, Couldn't take the pressure. Very sad
All I'll say is if this gets over $1.55 the last offering price, You'll have 2days to sell before the next offering, Just enough time to do the app for the filing
Will not happen, What about next week, NOPE
What about week AFTER, NOPE
What about week AFTER, NOPE
What about week AFTER, NOPE
What about week AFTER, NOPE
BG MEDICINE = The Perpetual Sea Of Hope
Next holiday week without news, And IMHO they wouldn't put a pr out on a holiday week.
This is going nowhere fast, Oh BTY Wheres the Gread King, LOL
Yup, You're right Jess, This stock is like the City Of Hope, First it was when they were saying ( this will explode when we get 510K Clearence ) Didn't happen, Then it was when Abbott releases news about BGMD's connection to Abbott, Didn't happen, Then it was Buy Out News, Some were saying this would go as High as $70.00 a share, Didn't happen, Then it was when we get delisting news this would fly, Didn't happen, Then it was when we get funding, Didnt happen, Now again its back to when Abbott puts out news release again, WHAT NEXT ?????
As for Rev's from this test, You wont see any Rev's from the Automated test till Mid 2016, If that.
As for Reverse Split, IMHO its a sure thing, 1 FOR 5
This may be why its holding up
Contemporaneously with the execution and delivery of the Purchase Agreement and the issuance of the Notes by the Company to the Purchasers, the Company and the Purchasers entered into a Security Agreement (the “Security Agreement”), dated May 12, 2015, pursuant to which the Company granted to the Purchasers a security interest in substantially all of the Company’s assets, other than the Company’s intellectual property, to secure the Company’s obligations under the Notes. Pursuant to the terms of the Security Agreement, the Company’s intellectual property will become subject to the security interest granted by the Company to the Purchasers upon repayment of all amounts owed under that certain Loan and Security Agreement by and among the Company, General Electric Capital Corporation (“GECC”) as Agent, the Lenders and the Guarantors dated as of February 10, 2012, as amended (“the “GECC Agreement”). Pursuant to a Subordination and Intercreditor Agreement by and among the Company, the Purchasers and GECC , dated May 12, 2015, entered into contemporaneously with the execution and delivery of the Purchase Agreement, the Company’s payment obligations under the Notes are
subordinated to the Company’s payment obligations under the GECC Agreement and the security interest granted by the Company to the Purchasers to secure the Company’s obligations under the Notes is subordinated to the security interest granted by the Company to GECC to secure the Company’s obligations under the GECC Agreement. In connection with the entry into the Purchase Agreement, the Company and GECC amended the GECC Agreement (the “GECC Amendment”), dated May 12, 2015, to, among other things, permit the Company to enter into the Purchase Agreement and related agreements.
Talk of R/S , Talk ofLiquidation Preference: Upon liquidation, including deemed liquidations pursuant to a merger, consolidation or a sale of all or substantially all of our assets, the holders of Series A Preferred Stock will be entitled to be paid first out of any proceeds in an amount per share equal to the price at which shares of Series A Preferred Stock were sold in the Financing, plus all accrued but unpaid dividends on each share of Series A Preferred Stock, and prior to payment of any amounts on the Company’s common stock. Thereafter, the holders of Series A Preferred Stock will also share pro rata on an as converted to common stock basis in payments made to the holders the Company’s common stock. Accordingly, the holders of the Series A Preferred Stock will be entitled to receive the proceeds out of any sale or liquidation of the Company before any such proceeds are paid to holders of the Company’s common stock and then share in any proceeds paid to holders of the Company’s common stock. In general, if the proceeds received upon any sale or liquidation do not exceed the total liquidation proceeds payable to the holders of the Series A Preferred Stock, which, prior to any adjustment in accordance with the terms of the Series A Preferred Stock is equal to the aggregate cash proceeds to be received by the Company in the Financing, holders of the Company’s common stock would receive no value for their shares upon such a sale or liquidation.
Jess, I can't imagine they would give no update tomorrow, Even they could not be that stupid, if there's no update tomorrow, You better pack your bags because this will be a long, long trip.
Exactly Jess, Way , Way to much excitement here, The BO numbers are pure fantasy, If there was a BO before this had a chance to put the Abbott Automated Assay out, TOP dollar would be $4.00 , And that's stretching it IMHO
We examine galectin-3 expression in CNS after EMCV inoculation.
Galectin-3 is up-regulated in several degenerated lesions 96 h after EMCV.
Iba-1 positive microglia was activated within and around the focus of infection.
Microlesions with a few galectin-3 positive cells were detected in cerebellum at 48 h.
Galectin-3 is a key mediator between viral infection and neuronal degeneration.
Galectin-3 is a β-galactosidase-binding lectin which is important in cell proliferation and apoptotic regulation. Encephalomyocarditis virus (EMCV), which includes the Enterovirus genus, can cause not only acute myocarditis but also neuronal degeneration of central nervous system in various animals including mice. The pathophysiological role of galectin-3 in central nervous system following acute viral infection is not fully understood. The goal of this study is to determine the localization and time-course of galectin-3 expression after acute viral inoculation with EMCV. Galectin-3 is up-regulated in degenerated lesions of brain area including cerebellum, hippocampus, thalamus and cerebral hemisphere, 96 h after EMCV inoculation. At the same time, Iba-1 positive microglia was morphologically activated within and around the focus of infection. Interestingly, in cerebellum, the microlesions containing a few galectin-3 cells were detected in the immediate-early phase of infection, as early as 48 h after EMCV inoculation. Thus, our results indicate that galectin-3 expression may be a key mediator between viral infection and neuronal degeneration in central nervous system including cerebellum. Furthermore, detection of galectin-3 might be an early diagnostic method for neuronal degeneration after virus infection.
That 4,106,071 Shares of Common Stock is based on the Number of shares outstanding at the time of the Agreement, The Agreement also states (( the number of shares which may be issued under the Purchase Agreement may not exceed an amount that would result in the Company breaching its obligations under the rules of the NASDAQ Global Market. In particular, the Company may not issue more than 4,106,071 shares, representing 19.99% of the total number of its outstanding shares on January 24, 2013 ))
What we dont know is will that 19.99% apply now with the OS at around 35M shares outstanding which would bring the total # shares to around 7M ?????
That would be great if it happens, But there is value beyond a Buyout, If I were only thinking Buyout, I would be very disappointed if it didn't happen.
Why don't you go away, Your contribution to this board is nonsense, You know nothing about investing or stocks, Your Investment plan is , GO GO GO ,GET LOST